May 28, 2020

May 27, 2020

Subscribe to Latest Legal News and Analysis

May 26, 2020

Subscribe to Latest Legal News and Analysis

Biotechnology, Life Sciences, Food and Drug Law News

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

Date Title Organization
2
Jul
FDA Warns of Rare but Potentially Severe Side Effects in Acne Drug Products Greenberg Traurig, LLP
2
Jul
New Alcohol and Tobacco Tax and Trade Bureau (TTB) FAQs on Sugar Claims McDermott Will & Emery
2
Jul
Examining the Impact of the Supreme Court's Limelight v. Akamai Decision [VIDEO] Sterne, Kessler, Goldstein & Fox P.L.L.C.
2
Jul
New Connecticut Pharmacy Rewards Disclosure Bill Took Effect July 1 Mintz
2
Jul
FDA Issues Guidance for Safety of Nanomaterials in Cosmetic Products (as well as in Food) Greenberg Traurig, LLP
1
Jul
Nanotechnology in Food Production: FDA Finalizes Guidance on Manufacturing Process Changes for Food Additives Michael Best & Friedrich LLP
1
Jul
New York State Legislature Approves Use of Medical Marijuana; Users to Be Considered "Disabled" Under State Human Rights Law Proskauer Rose LLP
1
Jul
FDA (Food and Drug Administration) Issues Long-Awaited Draft Guidance Documents Concerning Internet/Social Media Covington & Burling LLP
1
Jul
Energy & Environmental Law Update - June 30, 2014 Mintz
30
Jun
FDA Gives an Inch, But Only an Inch, on Use of Social Media to Promote Drugs and Devices Barnes & Thornburg LLP
30
Jun
FDA Issues Guidance on Use of Nanotechnology in Foods Barnes & Thornburg LLP
30
Jun
Trademark Rights around the World: It May Be BUDWEISER® in the US, But Not Everywhere Mintz
30
Jun
Supreme Court: Food, Drug, and Cosmetic Act (FDCA) Compliance Does Not Bar Lanham Act Claims - POM Wonderful LLC v. Coca-Cola Co. McDermott Will & Emery
28
Jun
Comment Period Closing Soon on New Food and Drug Administration (FDA) Food Transport Rule Beveridge & Diamond PC
27
Jun
FDA Draft Guidance - Best Practices for Developing Drug Trademarks - Food and Drug Administration Sterne, Kessler, Goldstein & Fox P.L.L.C.
27
Jun
Federal Judge Puts Narcolepsy Drug Horizontal Conspiracy Claims to Bed McDermott Will & Emery
26
Jun
VitaminsOnline.com Files False Advertising Action Over Competitor's Online Dietary Supplement Offerings and Claims Womble Bond Dickinson (US) LLP
26
Jun
Making Use of Social Media: FDA Releases Two Draft Guidelines on the Use of Social Media Platforms by Drug and Device Manufacturers Mintz
25
Jun
Is an Abbreviated Pathway for Biosimilars Coming Soon to China? Michael Best & Friedrich LLP
24
Jun
Food and Drug Administration (FDA) Relaxes Regulation of Certain Software Devices Covington & Burling LLP

Pages

LATEST LEGAL NEWS & ANALYSIS

TRENDING LEGAL ANALYSIS